DOI QR코드

DOI QR Code

Seroprevalence of Plasmodium vivax in the Republic of Korea (2003-2005) using Indirect Fluorescent Antibody Test

  • Kim, Tong-Soo (Department of Parasitology, College of Medicine, Inha University) ;
  • Kang, Yoon-Joong (Department of Biomedical Science, Jungwon University) ;
  • Lee, Won-Ja (Division of Malaria and Parasitic Diseases, National Institute of Health) ;
  • Na, Byoung-Kuk (Department of Parasitology and Institute of Health Sciences, Gyeongsang National University School of Medicine) ;
  • Moon, Sung-Ung (Department of International Medicine, Seoul National University, Bundang Hospital) ;
  • Cha, Seok Ho (Department of Biomedical Technology, Inha University School of Medicine) ;
  • Lee, Sung-Keun (Department of Pharmacology, Inha University School of Medicine) ;
  • Park, Yun-Kyu (Department of Parasitology, College of Medicine, Inha University) ;
  • Pak, Jhang-Ho (Asan Institute for Life Sciences, University of Ulsan College of Medicine, Asan Medical Center) ;
  • Cho, Pyo Yun (Department of Parasitology, College of Medicine, Inha University) ;
  • Sohn, Youngjoo (Department of Anatomy, College of Korean Medicine, Institute of Korean Medicine, Kyung Hee University) ;
  • Lee, Hyeong-Woo (Department of Pathology, Immunology, and Laboratory Medicine, College of Medicine, University of Florida)
  • 투고 : 2013.07.19
  • 심사 : 2013.09.16
  • 발행 : 2014.02.28

초록

Plasmodium vivax reemerged in the Republic of Korea (ROK) in 1993, and is likely to continue to affect public health. The purpose of this study was to measure levels of anti-P. vivax antibodies using indirect fluorescent antibody test (IFAT) in border areas of ROK, to determine the seroprevalence of malaria (2003-2005) and to plan effective control strategies. Blood samples of the inhabitants in Gimpo-si, Paju-si, and Yeoncheon-gun (Gyeonggi-do), and Cheorwon-gun (Gangwon-do) were collected and kept in Korea Centers for Disease Control and Prevention (KCDC). Out of a total of 1,774 serum samples tested, the overall seropositivity was 0.94% (n=17). The seropositivity was the highest in Paju-si (1.9%, 7/372), followed by Gimpo-si (1.4%, 6/425), Yeoncheon-gun (0.67%, 3/451), and Cheorwon-gun (0.19%, 1/526). The annual parasite incidence (API) in these areas gradually decreased from 2003 to 2005 (1.69, 1.09, and 0.80 in 2003, 2004, and 2005, respectively). The highest API was found in Yeoncheon-gun, followed by Cheorwon-gun, Paju-si, and Gimpo-si. The API ranking in these areas did not change over the 3 years. The seropositivity of Gimpo-si showed a strong linear relationship with the API of 2005 (r=0.9983, P=0.036). Seropositivity data obtained using IFAT may be useful for understanding malaria prevalence of relevant years, predicting future transmission of malaria, and for establishing and evaluating malaria control programs in affected areas.

키워드

참고문헌

  1. Mendis K, Sina BJ, Marchesini P, Carter R. The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg 2001; 64: 97-106. https://doi.org/10.4269/ajtmh.2001.64.97
  2. Chu JK. A century history of parasitology in Korea. Seoul, Korea. Kookje Kyoyok Munwha. 1986. p 1-144 (monograph in Korean)
  3. Chun CH, Kim JJ. Malaria in Korea. Korean Med 1959; 2: 63-66 (in Korean).
  4. National Malaria Eradication Service, Ministry of Health and Social Affairs, Republic of Korea. Malaria pre-eradication programme in Korea, 1961-1965. Seoul, Korea. Progress Report. 1966, p 44- 70 (in Korean).
  5. Paik YH, Rhee HI, Shim JC. Malaria in Korea. Jpn J Exp Med 1988; 58: 55-66.
  6. Soh CT, Lee KT, Im KI, Min DY, Ahn MH, Kim JJ, Yong TS. Current status of malaria in Korea. Yonsei Rep Trop Med 1985; 16:11-18.
  7. Chai IH, Lim GI, Yoon SN, Oh WI, Kim SJ, Chai JY. Occurrence of tertian malaria in a male patient who has never been abroad. Korean J Parasitol 1994; 32: 195-200 (in Korean). https://doi.org/10.3347/kjp.1994.32.3.195
  8. Cho SY, Kong Y, Park SM, Lee JS, Lim YA, Chae SL, Kho WG, Lee JS, Shim JC, Shin HK. Two vivax malaria cases detected in Korea. Korean J Parasitol 1994; 32: 281-284. https://doi.org/10.3347/kjp.1994.32.4.281
  9. Lee JS, Kho WG, Lee HW, Seo M, Lee WJ. Current status of vivax malaria among civilians in Korea. Korean J Parasitol 1998; 36:241-248. https://doi.org/10.3347/kjp.1998.36.4.241
  10. Jeffery GM, McWilson W, Collins WE, Lobel H. Application of the indirect fluorescent antibody method in a study of malaria endemicity in Mato Grosso, Brazil. Am Trop Med Hyg 1975; 24: 402-411. https://doi.org/10.4269/ajtmh.1975.24.402
  11. Vafa M, Israelsson E, Maiga B, Dolo A, Doumbo OK, Troye- Blomberg M. 2009. Relationship between immunoglobulin isotype response to Plasmodium falciparum blood stage antigens and parasitological indexes as well as splenomegaly in sympatric ethnic groups living in Mali. Acta Trop 2009; 109: 12-16. https://doi.org/10.1016/j.actatropica.2008.09.001
  12. Razakandrainibe R, Thonier V, Ratsimbasoa A, Rakotomalala E, Ravaoarisoa E, Raherinjafy R, Andrianantenaina H, Voahanginirina O, Rahasana TE, Carod JF, Domarle O, Menard D. Epidemiological situation of malaria in Madagascar: baseline data for monitoring the impact of malaria control programmes using serological markers. Acta Trop 2009; 111: 160-167. https://doi.org/10.1016/j.actatropica.2009.04.007
  13. Curado I, Dos Santos Malafronte R, de Castro Duarte AM, Kirchgatter K, Branquinho MS, Bianchi Galati EA. Malaria epidemiology in low-endemicity areas of the Atlantic Forest in the Vale do Ribeira, Sao Paulo, Brazil. Acta Trop 2006; 100: 54-62. https://doi.org/10.1016/j.actatropica.2006.09.010
  14. Cerutti,C, Jr, Boulos M, Coutinho AF, Hatab MC, Falqueto A, Rezende HR, Duarte AM, Collins W, Malafronte RS. Epidemiologic aspects of the malaria transmission cycle in an area of very low incidence in Brazil. Malar J 2007; 6: 33. https://doi.org/10.1186/1475-2875-6-33
  15. Collins EC, Skinner JC. The indirect fluorescent antibody test for malaria. Am J Top Med Hyg 1972; 21: 690-695. https://doi.org/10.4269/ajtmh.1972.21.690
  16. Wang DQ, Tang LH, Gu ZC, Zheng X, Yang MN. Application of the indirect fluorescent antibody assay in the study of malaria infection in the Yangtze River Three Gorges Reservoir, China. Malar J 2009; 8: 199. https://doi.org/10.1186/1475-2875-8-199
  17. Moody A. Rapid diagnostic tests for malaria parasites. Clin Microbiol Rev 2002; 15: 66-78. https://doi.org/10.1128/CMR.15.1.66-78.2002
  18. McKenzie FE, Prudhomme WA, Magill AJ, Forney JR, Permpanich B, Lucas C, Gasser RA Jr, Wongsrichanalai C. White blood cell counts and malaria. J Infect Dis 2005; 192: 323-330. https://doi.org/10.1086/431152
  19. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Psychology Press. 1988.
  20. Lee HW, Lee JS, Lee WJ, Cho SH, Lee HS. The evaluation of recombinant circumsporozoite protein in malaria diagnosis. Korean J Microbiol 1999; 36: 142-149 (in Korean).
  21. Snow RW, Gilles HM. The Anopheles vector. In Essential Malariology. 4th ed. London, UK. Arnold. 2002, p 59-84.
  22. Lee WJ, Kim HH, Hwang SM, Park MY, Kim NR, Cho SH, In TS, Kim JY, Sattabongkot J, Sohn Y, Kim H, Lee JK, Lee HW. Detection of an antibody against Plasmodium vivax in residents of Gimpo-si, South Korea, using an indirect fluorescent antibody test. Malar J 2011; 10: 19. https://doi.org/10.1186/1475-2875-10-19
  23. Park CG, Chwae YJ, Kim JI, Lee JH, Hur GM, Jeon BH, Ko HS, Han JE, Lee SJ, Park JW, Kaslow DC, Strickman D, Roh CS. Serologic responses of Korean soldiers serving in malaria-endemic areas during a recent outbreak of Plasmodium vivax. Am J Trop Med Hyg. 2000; 62: 720-725. https://doi.org/10.4269/ajtmh.2000.62.720
  24. Kho WG, Jang JY, Hong ST, Lee HW, Lee WJ, Lee JS. Border malaria characters of reemerging vivax malaria in the Republic of Korea. Korean J Parasitol 1999; 37: 71-76. https://doi.org/10.3347/kjp.1999.37.2.71
  25. Kim TS, Kim JS, Na BK, Lee WJ, Kim HC, Youn SK, Gwack J, Kim HS, Cho PY, Ahn SK, Cha SH, Park YK, Lee SK, Kang YJ, Sohn Y, Hong Y, Lee HW. Decreasing incidence of Plasmodium vivax in the Republic of Korea during 2010-2012. Malar J 2013; 12: 309. https://doi.org/10.1186/1475-2875-12-309